ArticlemedRxiv : the preprint server for health sciences2023
Genetic evidence for serum amyloid P component as a drug target for treatment of neurodegenerative disorders.
A Floriaan Schmidt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.